CAT
Caterpillar Inc.
CAT's fundamentals are strong, but it looks expensive: trading at 24x earnings, above its usual 18x. Analysts expect strong earnings growth, though they disagree widely on how much.
SUNE
SUNation Energy Inc.
There isn't enough reported data to score SUNE yet.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
SUNE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Unavailable | |
| Strong |
SUNE's balance sheet is currently strong, and its revenue is stable, but its profitability is under pressure. There isn't enough data to rate its cash flow.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
SUNE PE Valuation
SUNE has no meaningful PE right now: it lost money over the past year.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
SUNE Forward outlook
There aren't enough analyst estimates for SUNE to show an outlook.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT has the stronger earnings trend. Trailing diluted EPS is up 31% for CAT versus SUNE down 118%.
SUNE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2024 | -$108,600.00 | +$495,900.00 |
| Q1 2024 | -$121,500.00 | +$436,500.00 |
| Q4 2023 | -$121,500.00 | +$484,500.00 |
| Q3 2023 | -$589,500.00 | -$384,000.00 |
| Q2 2023 | -$604,500.00 | -259% |
| Q1 2023 | -$558,000.00 | -335% |
| Q4 2022 | -$606,000.00 | -426% |
| Q3 2020 | $66,000.00 | -75% |
SUNE is still losing money, but far less than before: $108,600.00 per share over the past year, against $606,000.00 at its worst in late 2022.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT has the edge over SUNE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over SUNE on profitability, with a higher operating margin.
SUNE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $8.2M | -38% |
| Q1 2026 | $7.2M | -43% |
| Q4 2025 | $27.2M | +77% |
| Q3 2025 | $19M | +29% |
| Q2 2025 | $13.1M | -3.6% |
| Q1 2025 | $12.6M | -4.4% |
| Q4 2024 | $15.4M | -21% |
| Q3 2024 | $14.7M | -20% |
SUNE's revenue is growing: $8M last quarter, down 38% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -39% | -22 points |
| Q1 2026 | -60% | -43 points |
| Q4 2025 | 11% | +53 points |
| Q3 2025 | -1.3% | +9.6 points |
| Q2 2025 | -17% | -1.6 points |
| Q1 2025 | -17% | -0.6 points |
| Q4 2024 | -42% | -30 points |
| Q3 2024 | -11% | -2.4 points |
SUNE's operating margin was −39% last quarter, down 22 points from the same quarter a year ago.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT has the stronger cash trend. Its trailing FCF is up 39% versus its history, compared with SUNE at up 30%.
SUNE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | $2.1M | +$4M |
| Q3 2025 | $2.4M | +$3.4M |
| Q4 2024 | -$1.9M | -1739% |
| Q3 2024 | -$980.3K | -255% |
| Q2 2024 | -$788.4K | +$827.1K |
| Q1 2024 | -$2.7M | -$2.2M |
| Q4 2023 | $116.7K | +$1.4M |
| Q3 2023 | $631.2K | -40% |
SUNE's free cash flow was −$3M over the past year, against −$4M the year before.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over SUNE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
SUNE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +138% | +364 shares |
| 1 year | +850% | +561 shares |
| 3 years | +3819% | +611 shares |
SUNE has 627 diluted shares, up 850% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | $3,233 |
| Q1 2024 | $2,865 |
| Q4 2023 | $7,217 |
| Q3 2023 | $24,895 |
| Q2 2023 | — |
| Q1 2023 | $6,291 |
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has more cash than debt.
SUNE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2025 | -0.7x | Net Cash |
| Q2 2020 | -31.4x | Net Cash |
| Q1 2020 | -9.6x | Net Cash |
| Q4 2019 | -3.7x | Net Cash |
| Q3 2019 | -5.1x | Net Cash |
SUNE has more cash than debt.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
SUNE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.1 | Neutral |
| Stochastic | 4.8 | Oversold |
SUNE's weekly RSI is 32 (neutral) and its Stochastic is 5 (oversold).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
SUNE PE vs Industrials Sector
| Metric | SUNE | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
SUNE has no meaningful PE right now: it lost money over the past year.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has the edge over SUNE on trend strength, trading above more of its moving averages.
SUNE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.13 | 8.5% below |
| 20 week MA | $2.39 | 18% below |
| 50 week MA | $1.86 | 4.8% above |
| 100 week MA | $46.2 | 96% below |
| 200 week MA | $50,588.0 | 100% below |
SUNE's trend is mixed: it's above one of its five weekly moving averages, and 100% below its 200-week average.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has finished every year since 2020 higher, and it's up 3.8% so far in 2026.
SUNE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $3,798,000.0 | $2,724,000.0 | -28% |
| 2021 | $2,724,000.0 | $1,482,000.0 | -46% |
| 2022 | $1,482,000.0 | $225,000.0 | -85% |
| 2023 | $225,000.0 | $88,800.0 | -61% |
| 2024 | $88,800.0 | $536.0 | -99% |
| 2025 | $536.0 | $1.10 | -100% |
| 2026 YTD | $1.10 | $1.95 | +77% |
SUNE has the edge over CAT on returns for 2026, with the stronger performance.